SCHEMBL22038920

SCHEMBL22038920

c1ccc(-c2cc(-c3ccc(-c4ccc5c(c4)C(c4ccccc4)(c4ccccc4)c4ccccc4-5)cc3)nc(-c3ccc(-c4cccnc4)cc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.51
▸ CYP19A1 P11511 2/20 0.45
▸ DHODH Q02127 1/20 0.42
▸ CYP11B1 P15538 3/20 0.42
▸ CYP11B2 P19099 3/20 0.42
▸ CYP17A1 P05093 1/20 0.42
▸ TDP2 O95551 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22037616 1.00 PDK2 (0.51) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22037924 1.00 PDK2 (0.51) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22038004 0.98 PDK2 (0.49) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22038342 0.98 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22037409 0.98 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22037571 0.98 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22037596 0.98 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22038939 0.97 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22037513 0.97 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2
SCHEMBL22037493 0.97 PDK2 (0.48) PDK2CYP19A1DHODHCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELOVL1, ELOVL6, ELOVL5 PDK2 2857/4885CYP19A1 1838/4885DHODH 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback